Literature DB >> 11914659

Increased soluble intercellular adhesion molecule-1, breast cancer and the acute phase response.

A D Blann1, G J Byrne, A D Baildam.   

Abstract

Abnormal levels of soluble intercellular adhesion molecule-1 (sICAM-1), C-reactive protein (CRP) and von Willebrand factor (vWf) are commonly found in breast and other cancers. However, the relationship between these molecules is unclear as raised sICAM-1 and vWf may simply reflect an acute phase response. We tested the hypothesis that raised sICAM-1 and vWf are related to the acute phase response by measuring both markers by enzyme-linked immunosorbent assay, and CRP by dry chemistry, in 40 women with breast cancer (cases) and 40 age-matched controls. All three markers were raised in the cases compared with the controls [sICAM-1 (mean +/- SD), 281 +/- 70 versus 230 +/- 40 ng/ml; vWf (mean +/- SD), 139 +/- 33 versus 106 +/- 16 IU/dl; CRP (median), 7 (interquartile range, 5-11) versus 5 (4-6) mg/dl; all P < 0.01]. However, sICAM-1 correlated strongly with CRP (r = 0.67, P < 0.001) in the cases but there was no significant relationship between vWf and CRP (r = -0.15, P = 0.351). There were no significant correlations in the controls. We conclude that raised sICAM-1 in breast cancer, like the acute phase response, reflects inflammation, and that raised vWf seems likely to be independent of the acute phase response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11914659     DOI: 10.1097/00001721-200203000-00012

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  6 in total

1.  A Novel Combination of C-Reactive Protein and Vascular Endothelial Growth Factor in Differential Diagnosis of Ascites.

Authors:  Ahmed Abdel-Razik; Nasser Mousa; Hatem Elalfy; Tarek Fouad Sheta; Mahmoud Awad; Mostafa Abdelsalam; Rania Elhelaly; Rasha Elzehery; Nawal S Gouda; Waleed Eldars
Journal:  J Gastrointest Cancer       Date:  2017-03

2.  Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors.

Authors:  Brandon L Pierce; Marian L Neuhouser; Mark H Wener; Leslie Bernstein; Richard N Baumgartner; Rachel Ballard-Barbash; Frank D Gilliland; Kathy B Baumgartner; Bess Sorensen; Anne McTiernan; Cornelia M Ulrich
Journal:  Breast Cancer Res Treat       Date:  2008-04-10       Impact factor: 4.872

3.  Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer.

Authors:  Paul J Mills; Sonia Ancoli-Israel; Barbara Parker; Loki Natarajan; Suzi Hong; Shamini Jain; Georgia R Sadler; Roland von Känel
Journal:  Brain Behav Immun       Date:  2007-08-15       Impact factor: 7.217

4.  Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients.

Authors:  Brandon L Pierce; Rachel Ballard-Barbash; Leslie Bernstein; Richard N Baumgartner; Marian L Neuhouser; Mark H Wener; Kathy B Baumgartner; Frank D Gilliland; Bess E Sorensen; Anne McTiernan; Cornelia M Ulrich
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

Review 5.  A systematic review of the association between circulating concentrations of C reactive protein and cancer.

Authors:  Katriina Heikkilä; Shah Ebrahim; Debbie A Lawlor
Journal:  J Epidemiol Community Health       Date:  2007-09       Impact factor: 3.710

6.  Operative invasiveness does not affect the prognosis of patients with non-small cell lung cancer.

Authors:  Nozomu Motono; Shun Iwai; Yoshihito Iijima; Katsuo Usuda; Hidetaka Uramoto
Journal:  BMC Pulm Med       Date:  2020-10-15       Impact factor: 3.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.